메뉴 건너뛰기




Volumn 9, Issue 4, 2005, Pages 470-479

Infectious risk in pediatric organ transplant recipients: Is it increased with the new immunosuppressive agents?

Author keywords

Children; Immunosuppressive treatment; Infectious risk; Solid organ transplantation

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CASPOFUNGIN; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; EVEROLIMUS; FLUCONAZOLE; GANCICLOVIR; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY CD3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POLYCLONAL ANTIBODY; PREDNISONE; RAPAMYCIN; RIFABUTIN; RIFAMPICIN; TACROLIMUS; TICARCILLIN; UNINDEXED DRUG;

EID: 23844521622     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00325.x     Document Type: Review
Times cited : (20)

References (94)
  • 1
    • 0038461996 scopus 로고    scopus 로고
    • The registry of the international society for heart and lung transplantation: Sixth official pediatric report - 2003
    • BOUCEK MM, EDWARDS LB, BERKELEY MK, et al. The registry of the international society for heart and lung transplantation: sixth official pediatric report - 2003. J Heart Lung Transplant 2003: 22: 636-652.
    • (2003) J Heart Lung Transplant , vol.22 , pp. 636-652
    • Boucek, M.M.1    Edwards, L.B.2    Berkeley, M.K.3
  • 2
    • 0034970802 scopus 로고    scopus 로고
    • The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: Renal transplantation from 1987 through 1998
    • SEIKALY M, Ho PL, EMMETT L, TEJANI A. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: Renal transplantation from 1987 through 1998. Pediatr Transplant 2001: 5: 215-231.
    • (2001) Pediatr Transplant , vol.5 , pp. 215-231
    • Seikaly, M.1    Ho, P.L.2    Emmett, L.3    Tejani, A.4
  • 3
    • 84860979330 scopus 로고    scopus 로고
    • United Network for Organ Sharing. Available at: http:// www.unos.org (accessed September 2003).
  • 4
    • 0035117692 scopus 로고    scopus 로고
    • Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry
    • GJERTSON DW, CECKA JM. Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry. Pediatr Transplant 2001: 5: 5-15.
    • (2001) Pediatr Transplant , vol.5 , pp. 5-15
    • Gjertson, D.W.1    Cecka, J.M.2
  • 5
    • 0037674660 scopus 로고    scopus 로고
    • Pediatric liver transplantation for biliary atresia: Results of primary grafts in 328 recipients
    • DIEM HV, EVRARD V, VINH HT, et al. Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. Transplantation 2003: 75: 1692-1697.
    • (2003) Transplantation , vol.75 , pp. 1692-1697
    • Diem, H.V.1    Evrard, V.2    Vinh, H.T.3
  • 7
    • 2942748305 scopus 로고    scopus 로고
    • Studies of pediatric liver transplantation 2002: Patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada
    • MARTIN SR, ATKISON P, ANAND R, LINDBLAD AS, The SPLIT Research Group. Studies of pediatric liver transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant 2004: 8: 273-283.
    • (2004) Pediatr Transplant , vol.8 , pp. 273-283
    • Martin, S.R.1    Atkison, P.2    Anand, R.3    Lindblad, A.S.4
  • 8
    • 0037184803 scopus 로고    scopus 로고
    • Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus
    • FRIDELL JA, JAIN A, REYES J, et al. Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. Transplantation 2002: 74: 1721-1724.
    • (2002) Transplantation , vol.74 , pp. 1721-1724
    • Fridell, J.A.1    Jain, A.2    Reyes, J.3
  • 9
    • 1442314095 scopus 로고    scopus 로고
    • Posttransplant infections now exceed acute rejection as cause for hospitalisation: A report of the NAPRTCS
    • DHARNIDHARKA VR, STABLEIN DM, HARMON WE. Posttransplant infections now exceed acute rejection as cause for hospitalisation: a report of the NAPRTCS. Am J Transplant 2004: 4: 384-389.
    • (2004) Am J Transplant , vol.4 , pp. 384-389
    • Dharnidharka, V.R.1    Stablein, D.M.2    Harmon, W.E.3
  • 10
    • 0034979524 scopus 로고    scopus 로고
    • Introduction to the immunocompromised host Society Consensus Conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients
    • RUBIN RH, SCHAFFNER A, SPEICH R. Introduction to the immunocompromised host Society Consensus Conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients. Clin Infect Dis 2001: 33(Suppl. 1): S1-S4.
    • (2001) Clin Infect Dis , vol.33 , Issue.SUPPL. 1
    • Rubin, R.H.1    Schaffner, A.2    Speich, R.3
  • 11
    • 1942449498 scopus 로고    scopus 로고
    • Trends in immunosuppressive strategies in pediatric kidney transplantation
    • STABLEIN DM, SAYEGH MH. Trends in immunosuppressive strategies in pediatric kidney transplantation. Am J Transplant 2003: 3(Suppl. 5): 285.
    • (2003) Am J Transplant , vol.3 , Issue.SUPPL. 5 , pp. 285
    • Stablein, D.M.1    Sayegh, M.H.2
  • 12
    • 17844368600 scopus 로고    scopus 로고
    • Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation
    • SARWAL MM, YORGIN PD, ALEXANDER S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001: 72: 13-21.
    • (2001) Transplantation , vol.72 , pp. 13-21
    • Sarwal, M.M.1    Yorgin, P.D.2    Alexander, S.3
  • 13
    • 0038350657 scopus 로고    scopus 로고
    • Steroid withdrawal after pediatric liver transplantation: A long-term follow-up study in 109 recipients
    • DIEM HV, SOKAL EM, JANSSEN M, OTTE JB, REDING R. Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients. Transplantation 2003: 75: 1664-1670.
    • (2003) Transplantation , vol.75 , pp. 1664-1670
    • Diem, H.V.1    Sokal, E.M.2    Janssen, M.3    Otte, J.B.4    Reding, R.5
  • 14
    • 0035189174 scopus 로고    scopus 로고
    • Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation
    • FLYNN JT, BUNCHMAN TE, SHERBOTIE JR. Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation. Pediatr Transplant 2001: 5: 439-446.
    • (2001) Pediatr Transplant , vol.5 , pp. 439-446
    • Flynn, J.T.1    Bunchman, T.E.2    Sherbotie, J.R.3
  • 16
    • 0033610688 scopus 로고    scopus 로고
    • Impact of acute rejection therapy on infections and malignancies in renal transplant recipients
    • JAMIL B, NICHOLLS K, BECKER GJ, WALKER RG. Impact of acute rejection therapy on infections and malignancies in renal transplant recipients. Transplantation 1999: 68: 1597-1619.
    • (1999) Transplantation , vol.68 , pp. 1597-1619
    • Jamil, B.1    Nicholls, K.2    Becker, G.J.3    Walker, R.G.4
  • 17
    • 0006986048 scopus 로고    scopus 로고
    • A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation
    • The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996: 61: 1029-1037.
    • (1996) Transplantation , vol.61 , pp. 1029-1037
  • 18
    • 0023834380 scopus 로고
    • Monitoring and complications of monoclonal therapy. Complications and monitoring of OKT3 therapy
    • THISTLETHWAITE JR, STUART JK, MAYES JT, et al. Monitoring and complications of monoclonal therapy. Complications and monitoring of OKT3 therapy. Am J Kidney Dis 1988: 11: 112-119.
    • (1988) Am J Kidney Dis , vol.11 , pp. 112-119
    • Thistlethwaite, J.R.1    Stuart, J.K.2    Mayes, J.T.3
  • 19
    • 0027537858 scopus 로고
    • Prophylactic OKT3 monoclonal antibody versus antilymphocyte globulins: A prospective, randomized study in 148 first cadaver kidney grafts
    • BROYER M, GAGNADOUX MF, GUEST G, et al. Prophylactic OKT3 monoclonal antibody versus antilymphocyte globulins: a prospective, randomized study in 148 first cadaver kidney grafts. Transplant Proc 1993: 25(1 Pt 1): 570-571.
    • (1993) Transplant Proc , vol.25 , Issue.1 PART 1 , pp. 570-571
    • Broyer, M.1    Gagnadoux, M.F.2    Guest, G.3
  • 20
    • 0033609459 scopus 로고    scopus 로고
    • Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection
    • HENGSTER P, PESCOVITZ MD, HYATT D, MARGREITER R, on behalf of the Roche study group. Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Transplantation 1999: 68: 310-313.
    • (1999) Transplantation , vol.68 , pp. 310-313
    • Hengster, P.1    Pescovitz, M.D.2    Hyatt, D.3    Margreiter, R.4
  • 21
    • 0035956726 scopus 로고    scopus 로고
    • Fatal primary infection due to human herpesvirus-6 variant a in a renal transplant recipient
    • ROSSI C, DELFORGE ML, JACOBS F, et al. Fatal primary infection due to human herpesvirus-6 variant A in a renal transplant recipient. Transplantation 2001: 71: 288-292.
    • (2001) Transplantation , vol.71 , pp. 288-292
    • Rossi, C.1    Delforge, M.L.2    Jacobs, F.3
  • 22
    • 0031736086 scopus 로고    scopus 로고
    • Human herpesvirus-6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection
    • DESJARDIN JA, GIBBONS L, CHO E, et al. Human herpesvirus-6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J Infect Dis 1998: 178: 1783-1786.
    • (1998) J Infect Dis , vol.178 , pp. 1783-1786
    • Desjardin, J.A.1    Gibbons, L.2    Cho, E.3
  • 23
    • 0034720716 scopus 로고    scopus 로고
    • Human herpesvirus-6 in liver transplant recipients
    • ROGERS J, ROHAL S, CARRIGAN DR, et al. Human herpesvirus-6 in liver transplant recipients. Transplantation 2000: 69: 2566-2573.
    • (2000) Transplantation , vol.69 , pp. 2566-2573
    • Rogers, J.1    Rohal, S.2    Carrigan, D.R.3
  • 24
    • 0029036766 scopus 로고
    • Pretransplantation assessment of the risk of lymphoproliferative disorder
    • WALKER RC, MARSHALL WF, STRICKLER JG, et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Inf Dis 1995: 20: 1346-1353.
    • (1995) Clin Inf Dis , vol.20 , pp. 1346-1353
    • Walker, R.C.1    Marshall, W.F.2    Strickler, J.G.3
  • 25
    • 0033561025 scopus 로고    scopus 로고
    • Lymphoproliferative disorders after organ transplantation in children
    • DROR Y, GREENBERG M, TAYLOR G, et al. Lymphoproliferative disorders after organ transplantation in children. Transplantation 1999: 67: 990-998.
    • (1999) Transplantation , vol.67 , pp. 990-998
    • Dror, Y.1    Greenberg, M.2    Taylor, G.3
  • 26
    • 0021331684 scopus 로고
    • Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy
    • BEVERIDGE T, KRUPP P, MCKIBBIN C. Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy. Lancet 1984: 1: 788.
    • (1984) Lancet , vol.1 , pp. 788
    • Beveridge, T.1    Krupp, P.2    Mckibbin, C.3
  • 27
    • 0021349053 scopus 로고
    • Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
    • STARZL TE, NALESNIK MA, PORTER KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984: 1: 583-587.
    • (1984) Lancet , vol.1 , pp. 583-587
    • Starzl, T.E.1    Nalesnik, M.A.2    Porter, K.A.3
  • 28
    • 0034661894 scopus 로고    scopus 로고
    • The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients
    • YOUNES BS, MCDIARMID SV, MARTIN MG, et al. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation 2000: 70: 94-99.
    • (2000) Transplantation , vol.70 , pp. 94-99
    • Younes, B.S.1    Mcdiarmid, S.V.2    Martin, M.G.3
  • 29
    • 0032573721 scopus 로고    scopus 로고
    • Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients
    • MCDIARMID SV, JORDAN S, LEE GS, et al. Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998: 66: 1604-1611.
    • (1998) Transplantation , vol.66 , pp. 1604-1611
    • Mcdiarmid, S.V.1    Jordan, S.2    Lee, G.S.3
  • 30
    • 0036677234 scopus 로고    scopus 로고
    • Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow-up and outcome
    • HOLMES RD, ORBAN-ELLER K, KARRER FR, ROWE DT, NARKEWICZ MR, SOKOL RJ. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow-up and outcome. Transplantation 2002: 74: 367-372.
    • (2002) Transplantation , vol.74 , pp. 367-372
    • Holmes, R.D.1    Orban-Eller, K.2    Karrer, F.R.3    Rowe, D.T.4    Narkewicz, M.R.5    Sokol, R.J.6
  • 31
    • 0036771833 scopus 로고    scopus 로고
    • Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: A report of the North American Pediatric Renal Transplant Cooperative Study
    • DHARNIDHARKA VR, Ho PL, STABLEIN DM, HARMON WE, TEJANI AH. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2002: 6: 396-399.
    • (2002) Pediatr Transplant , vol.6 , pp. 396-399
    • Dharnidharka, V.R.1    Ho, P.L.2    Stablein, D.M.3    Harmon, W.E.4    Tejani, A.H.5
  • 32
    • 0037910288 scopus 로고    scopus 로고
    • Epidemiology of systemic mycoses among renal-transplant recipients in India
    • JOHN GT, SHANKAR V, TALAULIKAR G, et al. Epidemiology of systemic mycoses among renal-transplant recipients in India. Transplantation 2003: 75: 1544-1551.
    • (2003) Transplantation , vol.75 , pp. 1544-1551
    • John, G.T.1    Shankar, V.2    Talaulikar, G.3
  • 33
    • 0027979333 scopus 로고
    • Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes
    • ALFIERI C, ALLISON AC, KIEFF E. Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes. Antimicrob Agents Chemother 1994: 38: 126-129.
    • (1994) Antimicrob Agents Chemother , vol.38 , pp. 126-129
    • Alfieri, C.1    Allison, A.C.2    Kieff, E.3
  • 34
    • 0242491828 scopus 로고    scopus 로고
    • Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation
    • CHERIKH WS, KAUFFMAN HM, MCBRIDE MA, MAGHIRANG J, SWINNEN LJ, HANTO DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation 2003: 76: 1289-1293.
    • (2003) Transplantation , vol.76 , pp. 1289-1293
    • Cherikh, W.S.1    Kauffman, H.M.2    Mcbride, M.A.3    Maghirang, J.4    Swinnen, L.J.5    Hanto, D.W.6
  • 35
    • 1942481824 scopus 로고    scopus 로고
    • Risk of PTLD and other malignancies in renal transplant patients treated with MMF: Prospective observational cohort study
    • ROBSON RA, OPELZ G, CECKA M, SHAH E, SACKS S, BUDDE M. Risk of PTLD and other malignancies in renal transplant patients treated with MMF: prospective observational cohort study. Am J Transplant 2003: 3(Suppl. 5): 187.
    • (2003) Am J Transplant , vol.3 , Issue.SUPPL. 5 , pp. 187
    • Robson, R.A.1    Opelz, G.2    Cecka, M.3    Shah, E.4    Sacks, S.5    Budde, M.6
  • 36
    • 0038054547 scopus 로고    scopus 로고
    • Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses
    • MAJEWSKI M, KORECKA M, JOERGENSEN J, et al. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses. Transplantation 2003: 75: 1710-1717.
    • (2003) Transplantation , vol.75 , pp. 1710-1717
    • Majewski, M.1    Korecka, M.2    Joergensen, J.3
  • 37
    • 23844528045 scopus 로고    scopus 로고
    • Sirolimus inhibits cell growth and the expression of cyclin proteins in EBV-associated B cell lymphomas derived from patients with PTLD
    • BALATONI CE, NEPOMUCENO RR, KRAMS SM, MARTINEZ OM. Sirolimus inhibits cell growth and the expression of cyclin proteins in EBV-associated B cell lymphomas derived from patients with PTLD. Am J Transplant 2003: 3(Suppl. 5): 327.
    • (2003) Am J Transplant , vol.3 , Issue.SUPPL. 5 , pp. 327
    • Balatoni, C.E.1    Nepomuceno, R.R.2    Krams, S.M.3    Martinez, O.M.4
  • 38
    • 0035956745 scopus 로고    scopus 로고
    • A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts
    • MACDONALD AS for the Rapamune Global Study Group A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001: 71: 271-280.
    • (2001) Transplantation , vol.71 , pp. 271-280
    • Macdonald, A.S.1
  • 39
    • 1942449437 scopus 로고    scopus 로고
    • Low incidence of malignancy among renal recipients treated with sirolimus (SRL)-cyclosporine (CSA) regimen
    • YAKUPOGLU Y, KAHAN B. Low incidence of malignancy among renal recipients treated with sirolimus (SRL)-cyclosporine (CSA) regimen. Am J Transplant 2003: 3(Suppl. 5): 186.
    • (2003) Am J Transplant , vol.3 , Issue.SUPPL. 5 , pp. 186
    • Yakupoglu, Y.1    Kahan, B.2
  • 40
    • 2942726283 scopus 로고    scopus 로고
    • Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma
    • JIMENEZ-RIVERA C, AVITZUR Y, FECTEAU AH, JONES N, GRANT D, NG VL. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Pediatr Transplant 2004: 8: 243-245.
    • (2004) Pediatr Transplant , vol.8 , pp. 243-245
    • Jimenez-Rivera, C.1    Avitzur, Y.2    Fecteau, A.H.3    Jones, N.4    Grant, D.5    Ng, V.L.6
  • 41
    • 0034805094 scopus 로고    scopus 로고
    • Target of rapamycin (TOR) inhibition in renal transplantation: Clinical uses in various populations
    • PESCOVITZ MD, GOVANI M. Target of rapamycin (TOR) inhibition in renal transplantation: clinical uses in various populations. Am J Kidney Dis 2001: 38(Suppl. 2): S16-S21.
    • (2001) Am J Kidney Dis , vol.38 , Issue.SUPPL. 2
    • Pescovitz, M.D.1    Govani, M.2
  • 42
    • 0037184316 scopus 로고    scopus 로고
    • Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporine
    • FLECHNER SM, GOLDFARB D, MODLIN C, et al. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 2002: 74: 1070-1076.
    • (2002) Transplantation , vol.74 , pp. 1070-1076
    • Flechner, S.M.1    Goldfarb, D.2    Modlin, C.3
  • 44
    • 0024266511 scopus 로고
    • The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer
    • TUR-KASPA R, SHAUL Y, MOORE DD, et al. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 1988: 167: 630-633.
    • (1988) Virology , vol.167 , pp. 630-633
    • Tur-Kaspa, R.1    Shaul, Y.2    Moore, D.D.3
  • 45
    • 0042835566 scopus 로고    scopus 로고
    • Natural history of hepatitis C and outcomes following liver transplantation
    • CHARLTON M. Natural history of hepatitis C and outcomes following liver transplantation. Clin Liver Dis 2003: 7: 585-602.
    • (2003) Clin Liver Dis , vol.7 , pp. 585-602
    • Charlton, M.1
  • 46
    • 0042967970 scopus 로고    scopus 로고
    • Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor necrosis progression
    • MALUCCIO M, SHARMA V, LAGMAN M, et al. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor necrosis progression. Transplantation 2003: 76: 597-602.
    • (2003) Transplantation , vol.76 , pp. 597-602
    • Maluccio, M.1    Sharma, V.2    Lagman, M.3
  • 47
    • 0036754444 scopus 로고    scopus 로고
    • Everolimus (Certican) in combination with Neoral in pediatric renal transplant recipients: Interim analysis after 3 months
    • VESTER U, KRANZ B, WEHR S, BOGER R, HOYER PF, Rad B 351 Study Group. Everolimus (Certican) in combination with Neoral in pediatric renal transplant recipients: interim analysis after 3 months. Transplant Proc 2002: 34: 2209-2210.
    • (2002) Transplant Proc , vol.34 , pp. 2209-2210
    • Vester, U.1    Kranz, B.2    Wehr, S.3    Boger, R.4    Hoyer, P.F.5    Rad, B.6
  • 48
    • 2542609091 scopus 로고    scopus 로고
    • Wound-healing complications after kidney transplantation: A prospective, randomized comparison of sirolimus and tacrolimus
    • DEAN PG, LUND WJ, LARSON TS, et al. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004: 77: 1555-1561.
    • (2004) Transplantation , vol.77 , pp. 1555-1561
    • Dean, P.G.1    Lund, W.J.2    Larson, T.S.3
  • 49
    • 0035886032 scopus 로고    scopus 로고
    • Rapamycin: Clinical results and future opportunities
    • KAHAN BD, CAMARDO JS. Rapamycin: clinical results and future opportunities. Transplantation 2001: 72: 1181-1193.
    • (2001) Transplantation , vol.72 , pp. 1181-1193
    • Kahan, B.D.1    Camardo, J.S.2
  • 50
    • 0345118182 scopus 로고    scopus 로고
    • Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil
    • VAN GELDER T, TER MEULEN CG, HENE R, WEIMAR W, HOITSMA A. Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil. Transplantation 2003: 75: 788-791.
    • (2003) Transplantation , vol.75 , pp. 788-791
    • Van Gelder, T.1    Ter Meulen, C.G.2    Hene, R.3    Weimar, W.4    Hoitsma, A.5
  • 51
    • 0034721757 scopus 로고    scopus 로고
    • Conversion to rapamycin (sirolimus) immunosuppression in renal transplant recipients: Report of an initial experience
    • DOMINGUEZ J, MAHALATI K, KIBERD B, MCAUSTER VC, MACDONALD AS. Conversion to rapamycin (sirolimus) immunosuppression in renal transplant recipients: report of an initial experience. Transplantation 2000: 70: 1244-1247.
    • (2000) Transplantation , vol.70 , pp. 1244-1247
    • Dominguez, J.1    Mahalati, K.2    Kiberd, B.3    Mcauster, V.C.4    Macdonald, A.S.5
  • 52
    • 0345161813 scopus 로고    scopus 로고
    • Sirolimus (rapamycin)-based therapy in human renal transplantation
    • GROTH CG, BACKMAN L, MORALES JM, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation. Transplantation 1999: 67: 1036-1042.
    • (1999) Transplantation , vol.67 , pp. 1036-1042
    • Groth, C.G.1    Backman, L.2    Morales, J.M.3
  • 53
    • 0035960312 scopus 로고    scopus 로고
    • Provocative effects of the immunosuppressants rapamycin, tacrolimus, and dexamethasone on Pneumocystis carinii pneumonitis in contrast to the anti- Pneumocystis carinii pneumonitis effects of mycophenolate mofetil
    • OZ HS, HUGHES WT, VARILEK G. Provocative effects of the immunosuppressants rapamycin, tacrolimus, and dexamethasone on Pneumocystis carinii pneumonitis in contrast to the anti- Pneumocystis carinii pneumonitis effects of mycophenolate mofetil. Transplantation 2001: 72: 1464-1466.
    • (2001) Transplantation , vol.72 , pp. 1464-1466
    • Hs, O.Z.1    Hughes, W.T.2    Varilek, G.3
  • 54
    • 0033610638 scopus 로고    scopus 로고
    • Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial
    • KAHAN BD, JULIAN BA, PESCOVITZ MD, VANRENTERGHEM Y, NEYLAN J for the Rapamune Study Group. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: a phase II trial. Transplantation 1999: 68: 1526-1532.
    • (1999) Transplantation , vol.68 , pp. 1526-1532
    • Kahan, B.D.1    Julian, B.A.2    Pescovitz, M.D.3    Vanrenterghem, Y.4    Neylan, J.5
  • 55
    • 0034691321 scopus 로고    scopus 로고
    • Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients
    • MORELON E, STERN M, KREIS H. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients. N Engl J Med 2000: 343: 225-226.
    • (2000) N Engl J Med , vol.343 , pp. 225-226
    • Morelon, E.1    Stern, M.2    Kreis, H.3
  • 56
    • 0034649707 scopus 로고    scopus 로고
    • Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients
    • SINGER SJ, TIERMAN R, SULLIVAN EJ. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients. N Engl J Med 2000: 343: 1815-1816.
    • (2000) N Engl J Med , vol.343 , pp. 1815-1816
    • Singer, S.J.1    Tierman, R.2    Sullivan, E.J.3
  • 58
    • 0242585412 scopus 로고    scopus 로고
    • Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches
    • GINEVRI F, DE SANTIS R, COMOLI P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003: 75: 1266-1270.
    • (2003) Transplantation , vol.75 , pp. 1266-1270
    • Ginevri, F.1    De Santis, R.2    Comoli, P.3
  • 60
    • 0038684561 scopus 로고    scopus 로고
    • Incidence of polyomavirus-nephropathy in renal allografts: Influence of modern immunosuppressive drugs
    • MENGEL M, MARWEDEL M, RADERMACHER J, et al. Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003: 18: 1190-1196.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 1190-1196
    • Mengel, M.1    Marwedel, M.2    Radermacher, J.3
  • 61
    • 33645264746 scopus 로고    scopus 로고
    • Frequency of polyomavirus-associated nephropathy in a randomized controlled trial of tacrolimus versus sirolimus-based immunosuppression
    • HAMAD A, BUEHRIG CK, KREPS MA, et al. Frequency of polyomavirus- associated nephropathy in a randomized controlled trial of tacrolimus versus sirolimus-based immunosuppression. Am J Transplant 2003: 3(Suppl. 5): 189.
    • (2003) Am J Transplant , vol.3 , Issue.SUPPL. 5 , pp. 189
    • Hamad, A.1    Buehrig, C.K.2    Kreps, M.A.3
  • 62
    • 0035967217 scopus 로고    scopus 로고
    • Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine
    • LI B, HARTONO C, DING R, SHARMA VK, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001: 344: 947-954.
    • (2001) N Engl J Med , vol.344 , pp. 947-954
    • Li, B.1    Hartono, C.2    Ding, R.3    Sharma, V.K.4
  • 63
    • 0036138843 scopus 로고    scopus 로고
    • Immune monitoring in kidney transplant recipients revisited
    • HEEGER PS, HRICIK D. Immune monitoring in kidney transplant recipients revisited. J Am Soc Nephrol 2002: 13: 288-290.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 288-290
    • Heeger, P.S.1    Hricik, D.2
  • 64
    • 0036802558 scopus 로고    scopus 로고
    • Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children
    • FILLER G, FEBER J, LEPAGE N, WEILER G, MAI I. Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children. Pediatr Transplant 2002: 6: 411-418.
    • (2002) Pediatr Transplant , vol.6 , pp. 411-418
    • Filler, G.1    Feber, J.2    Lepage, N.3    Weiler, G.4    Mai, I.5
  • 65
    • 0036642453 scopus 로고    scopus 로고
    • The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials
    • HUSAIN S, SINGH N. The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials. Clin Infect Dis 2002: 35: 53-61.
    • (2002) Clin Infect Dis , vol.35 , pp. 53-61
    • Husain, S.1    Singh, N.2
  • 66
    • 0032707065 scopus 로고    scopus 로고
    • Cyclosporin a and imipenem associated seizure activity in allogeneic bone marrow transplantation patients
    • TURHAL NS. Cyclosporin A and imipenem associated seizure activity in allogeneic bone marrow transplantation patients. J Chemother 1999: 11: 410-413.
    • (1999) J Chemother , vol.11 , pp. 410-413
    • Turhal, N.S.1
  • 68
    • 0034979484 scopus 로고    scopus 로고
    • Pretransplant evaluation for infections in donors and recipients of solid organs
    • SCHAFFNER A. Pretransplant evaluation for infections in donors and recipients of solid organs. Clin Infect Dis 2001: 33(Suppl. 1): S9-S14.
    • (2001) Clin Infect Dis , vol.33 , Issue.SUPPL. 1
    • Schaffner, A.1
  • 69
    • 0034991356 scopus 로고    scopus 로고
    • Posttransplant microbiological surveillance
    • SNYDMAN DR. Posttransplant microbiological surveillance. Clin Infect Dis 2001: 33(Suppl. 1): S22-S25.
    • (2001) Clin Infect Dis , vol.33 , Issue.SUPPL. 1
    • Snydman, D.R.1
  • 71
    • 0037294480 scopus 로고    scopus 로고
    • Serial detection of Ebstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative disease
    • JAEGER CH, ABOU-AJRAM C, NITSCHKO H, et al. Serial detection of Ebstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative disease. Pediatr Transplant 2003: 7: 46-52.
    • (2003) Pediatr Transplant , vol.7 , pp. 46-52
    • Jaeger, C.H.1    Abou-Ajram, C.2    Nitschko, H.3
  • 72
    • 0347320476 scopus 로고    scopus 로고
    • Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease
    • CARPENTIER L, TAPIERO B, ALVAREZ F, VIAU C, ALFIERI C. Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease. J Infect Dis 2003: 188: 1853-1864.
    • (2003) J Infect Dis , vol.188 , pp. 1853-1864
    • Carpentier, L.1    Tapiero, B.2    Alvarez, F.3    Viau, C.4    Alfieri, C.5
  • 73
    • 0037228013 scopus 로고    scopus 로고
    • Quantitative tissue polymerase chain reaction for Epstein-Barr virus in pediatric solid organ recipients
    • GUPTA M, FILLER G, KOVESI T, et al. Quantitative tissue polymerase chain reaction for Epstein-Barr virus in pediatric solid organ recipients. Am J Kidney Dis 2003: 41: 212-219.
    • (2003) Am J Kidney Dis , vol.41 , pp. 212-219
    • Gupta, M.1    Filler, G.2    Kovesi, T.3
  • 74
    • 0034999611 scopus 로고    scopus 로고
    • The Epstein-Barr virus and post-transplant lymphoproliferative disease interplay of immunosuppression, EBV, and the immune system in disease pathogenesis
    • TANNER JE, ALFIERI C. The Epstein-Barr virus and post-transplant lymphoproliferative disease interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transpl Infect Dis 2001: 3: 60-69.
    • (2001) Transpl Infect Dis , vol.3 , pp. 60-69
    • Tanner, J.E.1    Alfieri, C.2
  • 75
    • 0026597372 scopus 로고
    • Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3
    • HIBBERD PL, TOLKOFF-RUBIN NE, COSIMI AB, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 1992: 53: 68-72.
    • (1992) Transplantation , vol.53 , pp. 68-72
    • Hibberd, P.L.1    Tolkoff-Rubin, N.E.2    Cosimi, A.B.3
  • 76
    • 0037374523 scopus 로고    scopus 로고
    • Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients
    • SINGH N. Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients. Lancet Infect Dis 2003: 3: 156-161.
    • (2003) Lancet Infect Dis , vol.3 , pp. 156-161
    • Singh, N.1
  • 77
    • 0037955523 scopus 로고    scopus 로고
    • Tolerance induction in clinical transplantation: The pending questions
    • TOUNGOUZ M, DONCKIER V, GOLDMAN M. Tolerance induction in clinical transplantation: the pending questions. Transplantation 2003: 75: 58S-60S.
    • (2003) Transplantation , vol.75
    • Toungouz, M.1    Donckier, V.2    Goldman, M.3
  • 78
    • 0034984568 scopus 로고    scopus 로고
    • Epidemiology of infections after solid-organ transplantation
    • SNYDMAN DR. Epidemiology of infections after solid-organ transplantation. Clin Infect Dis 2001: 33(Suppl. 1): S5-S8.
    • (2001) Clin Infect Dis , vol.33 , Issue.SUPPL. 1
    • Snydman, D.R.1
  • 79
    • 0037294479 scopus 로고    scopus 로고
    • Human herpesvirus-6 and -7 infections in transplantation
    • YOSHIKAWA T. Human herpesvirus-6 and -7 infections in transplantation. Pediatr Transplant 2003: 7: 11-17.
    • (2003) Pediatr Transplant , vol.7 , pp. 11-17
    • Yoshikawa, T.1
  • 80
    • 0026543499 scopus 로고
    • Adenovirus infection in pediatric liver transplant recipients
    • MICHAELS MG, GREEN M, WALD ER, STARZL TE. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 1992: 165: 170-174.
    • (1992) J Infect Dis , vol.165 , pp. 170-174
    • Michaels, M.G.1    Green, M.2    Wald, E.R.3    Starzl, T.E.4
  • 81
    • 0038299439 scopus 로고    scopus 로고
    • Adenovirus infection in pediatric small bowel transplantation recipients
    • PINCHOFF RJ, KAUFMAN SS, MAGID MS, et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 2003: 76: 183-189.
    • (2003) Transplantation , vol.76 , pp. 183-189
    • Pinchoff, R.J.1    Kaufman, S.S.2    Magid, M.S.3
  • 82
    • 0034838394 scopus 로고    scopus 로고
    • Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation
    • BROLIDEN K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant 2003: 5: 320-330.
    • (2003) Pediatr Transplant , vol.5 , pp. 320-330
    • Broliden, K.1
  • 83
    • 0036265803 scopus 로고    scopus 로고
    • Discrimination between acute rejection and adenoviral enteritis in intestinal transplant recipients
    • KAUFMAN SS, MAGID MS, TSCHEMIA A, LELEIKO NS, FISHBEIN TM. Discrimination between acute rejection and adenoviral enteritis in intestinal transplant recipients. Transplant Proc 2002: 34: 943-945.
    • (2002) Transplant Proc , vol.34 , pp. 943-945
    • Kaufman, S.S.1    Magid, M.S.2    Tschemia, A.3    Leleiko, N.S.4    Fishbein, T.M.5
  • 86
    • 0031786786 scopus 로고    scopus 로고
    • The use of antibodies against the IL-2 receptor in transplantation
    • WALDMANN TA, O'SHEA J. The use of antibodies against the IL-2 receptor in transplantation. Curr Opin Immunol 1998: 10: 507-512.
    • (1998) Curr Opin Immunol , vol.10 , pp. 507-512
    • Waldmann, T.A.1    O'Shea, J.2
  • 87
    • 0035798924 scopus 로고    scopus 로고
    • Basiliximab in pediatric liver-transplant recipients
    • GANSCHOW R, GRABHOM E, BURDELSKI M. Basiliximab in pediatric liver-transplant recipients. Lancet 2001: 357: 388.
    • (2001) Lancet , vol.357 , pp. 388
    • Ganschow, R.1    Grabhom, E.2    Burdelski, M.3
  • 89
    • 0034810020 scopus 로고    scopus 로고
    • Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients
    • ETTENGER RB, GRIMM EM. Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients. Am J Kidney Dis 2001: 4(Suppl. 2): S22-S28.
    • (2001) Am J Kidney Dis , vol.4 , Issue.SUPPL. 2
    • Ettenger, R.B.1    Grimm, E.M.2
  • 90
    • 0030832514 scopus 로고    scopus 로고
    • SDZ RAD, a new rapamycin derivate. Pharmacological properties in vitro and in vivo
    • SCHULER W, SEDRANI R, COTTENS S, et al. SDZ RAD, a new rapamycin derivate. Pharmacological properties in vitro and in vivo. Transplantation 1997: 64: 36-42.
    • (1997) Transplantation , vol.64 , pp. 36-42
    • Schuler, W.1    Sedrani, R.2    Cottens, S.3
  • 91
    • 0036246092 scopus 로고    scopus 로고
    • Single-dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patients
    • VAN DAMME-LOMBAERTS R, WEBB N, HOYER PF, et al. Single-dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patients. Pediatr Transplant 2002: 6: 147-152.
    • (2002) Pediatr Transplant , vol.6 , pp. 147-152
    • Van Damme-Lombaerts, R.1    Webb, N.2    Hoyer, P.F.3
  • 92
    • 0027786826 scopus 로고
    • Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil
    • ALLISON AC, EUGUI EM. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993: 136: 5-28.
    • (1993) Immunol Rev , vol.136 , pp. 5-28
    • Allison, A.C.1    Eugui, E.M.2
  • 93
    • 0036227007 scopus 로고    scopus 로고
    • Effect of voriconazole on the pharmacokinetics in renal transplant patients
    • ROMERO AJ, POGAMP PL, NILSSON LG, WOOD N. Effect of voriconazole on the pharmacokinetics in renal transplant patients. Clin Pharmacol Ther 2002: 71: 226-234.
    • (2002) Clin Pharmacol Ther , vol.71 , pp. 226-234
    • Romero, A.J.1    Pogamp, P.L.2    Nilsson, L.G.3    Wood, N.4
  • 94
    • 0035165253 scopus 로고    scopus 로고
    • Possible interaction between intravenous azithromycin and oral cyclosporine
    • PAGE RL, RUSCIN JM, FISH D, LAPOINTE M. Possible interaction between intravenous azithromycin and oral cyclosporine. Pharmacotherapy 2001: 21: 1436-1443.
    • (2001) Pharmacotherapy , vol.21 , pp. 1436-1443
    • Page, R.L.1    Ruscin, J.M.2    Fish, D.3    Lapointe, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.